Using a Brief Negative Symptom Scale (BNSS) to assess negative symptoms of schizophrenia may bridge the gap between clinical interviews and a patient's self-reported measure of symptoms.
Study revealed the place in which a person lived at the age of fifteen was a big influence on the risk of developing both affective psychosis (bipolar disorder) and non-affective psychosis (schizophrenia) later in life.
The association between exposure to socio-economic and environmental risks for psychosis and psychotic-like experiences are present during late childhood, much earlier than previously believed. The findings could assist in assessing risk factors for the development of schizophrenia later in life.
Lower gray matter volume in the brain is indicative of a higher risk of developing mental health disorders including depression and psychosis. However, those with slightly greater gray matter volume were more likely to recover from their disorders. Researchers believe reduced gray matter volume may be linked to higher levels of inflammation, reduced concentration, and other cognitive impairments associated with disorders like schizophrenia.
Researchers say 80% of people taking antipsychotics to manage schizophrenia or bipolar disorder experience considerable weight gain. Some patients report up to 33kg of weight gain following taking antipsychotic medications. A new study aims to explore ways of managing weight gain for patients taking antipsychotics.
Vaccinated people with a history of mental health disorders including bipolar disorder, psychosis, and anxiety, have a 24% increased risk of contracting COVID-19, a new study reports.
Genes associated with inflammation were linked to reduced gray matter in brain areas associated with neuropsychiatric disorders. The findings shed new light on how neurodevelopmental psychiatric disorders such as schizophrenia and ASD may occur.
People who use illicit amphetamines are at a 5-fold higher risk of developing psychosis, a new study reports.
Tissue in specific brain areas increases in patients with psychosis, even before they receive treatment.